BRAF and melanoma: Straussman et al. investigated several different cancer cell lines and stromal cell types, showing that specifically in BRAF-mutant melanoma cells, stroma-mediated resistance to RAF inhibition was conferred by stromal secretion of HGF, a commonly described product of CAF cells [129].